British Heart Foundation announces changes to its Board of Trustees

Posted by pt91 at Sep 24, 2015 03:23 PM |
Emeritus Professor from University of Leicester takes on new roles

Issued by British Heart Foundation on 24 September 2015

The British Heart Foundation (BHF) has announced changes to its Board of Trustees, including three new members, following retirements.

Professor Sir Kent Woods will take on the newly created role of Senior Medical Trustee, while also becoming Vice Chair, and Chair of the BHF Advisory Council, following the retirement of Sir Christopher Edwards. Sir Kent was the Chief Executive of the Medicines and Healthcare Products Regulatory Agency (MHRA) between 2004 and 2013, and has been Chairman of the Management Board of the European Medicines Agency since 2011.

Iain Mackay will replace Roger Pilgrim, who is retiring after seven years, as Trustee and Chair of the Audit and Risk Committee.
Mr Mackay is Group Finance Director of HSBC Holdings Plc, a role he has held since December 2010. Before joining HSBC in 2007, Mr Mackay was at General Electric - initially as Controller of the Global Consumer Finance unit, and then became CFO of GE Healthcare - Global Diagnostic Imaging.

Professor Sussan Nourshargh is replacing Professor Kay-Tee Khaw as Trustee following Professor Khaw’s retirement after nine years as a BHF Trustee. Professor Nourshargh is a pharmacologist who became Professor of Immunopharmacology at Imperial College London in 2006 and since 2007 has been Professor of Microvascular Pharmacology at Barts and The London Medical School, Queen Mary, University of London. She is a Wellcome Trust Senior Investigator and Fellow of the Academy of Medical Sciences.

All three board changes will come into effect on October 1st following the Annual General Meeting, when Dr Doug Gurr will also begin as new Chairman of the BHF.

The BHF announced in March that Dr Gurr would replace Philip Yea in the role of Chair of the Board of Trustees. Dr Gurr has been the President of Amazon China since 2014.

Mr Yea became a Trustee at the British Heart Foundation in 2008 and was appointed chairman the following year. He is stepping down after serving the maximum terms as a Trustee.

The BHF is the UK’s leading heart charity and the largest independent funder of cardiovascular research.  A quarter of all deaths in the UK are caused by cardiovascular disease and there are an estimated seven million people living with the condition.

For over 50 years the BHF has invested in world leading research that has helped transform the lives of people living with heart and circulatory conditions. There are around 188,000 hospital episodes attributed to heart attack in the UK each year, meaning someone suffers a heart attack every three minutes, but successful research has led to treatments that mean seven in ten people now survive.

ENDS

For more information please call the BHF press office on 020 7554 0164 (out of hours) or email newsdesk@bhf.org.uk

Notes to editors

Professor Sir Kent Woods
Sir Kent Woods was the Chief Executive of the Medicines and Healthcare Products Regulatory Agency (MHRA) 2004-2013 and has been Chairman of the Management Board of the European Medicines Agency since 2011. He was previously Director of the NHS Health Technology Assessment Programme (1999-2003), commissioning research in and for the NHS. A graduate of Cambridge and of Harvard School of Public Health, he was a consultant physician in cardiovascular medicine at Leicester Royal Infirmary from 1984-2003 and is Emeritus Professor of Therapeutics at Leicester University.  He is a Fellow of the Academy of Medical Sciences and was knighted for services to healthcare in 2011.

Iain Mackay
Iain Mackay is Group Finance Director of HSBC Holdings Plc, a role he has held since December 2010. Iain joined HSBC in 2007 as CFO of HSBC North America Holdings Inc where he was instrumental in the restructuring of HSBC's consumer finance business. From 2009-2010 he was CFO Asia Pacific of HSBC Holdings Plc. Before joining HSBC, Iain was at General Electric - initially as Controller of the Global Consumer Finance unit, then CFO of GE Healthcare - Global Diagnostic Imaging. From 1990-1996, Iain was a regional finance director with Schlumberger Dowell. Early in his career, Iain was with PriceWaterhouse in New York and Paris and Thomson McLintock, KMG in the UK.

Professor Sussan Nourshargh
Professor Sussan Nourshargh is a pharmacologist who studied at University College London and King’s College London and became Professor of Immunopharmacology at Imperial College London in 2006. In 2007 she joined Barts and The London Medical School, Queen Mary, University of London, to establish and head a new Centre focusing on Microvascular Research. Her research focuses on unravelling the molecular and cellular events involved in leukocyte trafficking and through the application of advanced in vivo imaging modalities she has made seminal contributions to the fields of inflammation and vascular biology. Professor Nourshargh is a Wellcome Trust Senior Investigator and Fellow of the Academy of Medical Sciences, British Pharmacological Society and Royal Society of Biology. She has acted on numerous funding Boards including BHF Project Grant and Fellowship Committees and is currently on the Board of the Wellcome Trust’s Biomedical Resources & Multi-User Equipment Committee, Royal Society’s Newton Advanced Fellowship Panel and she chairs the Academy of Medical Sciences Committee for selection of new Fellows in the fields of pharmacology, physiology and neurosciences. Sussan has also been on the panel of numerous national and international scientific advisory boards, has been recipient of several prestigious scientific awards, has held a number of editorial positions and is currently on the Editorial Board of the European Journal of Immunology.

Dr Doug Gurr
Dr Gurr became President of Amazon China in 2014 after joining Amazon UK in 2011. He has been a Trustee of the Landmark Trust since 2014. Dr Gurr was a Trustee of the Science Museum from 2004-2014 and was Chairman between 2010 and 2014. From 2006 to 2011 he was Executive Development Director at Asda and a main Board Director of Asda Group Limited. He spent five years as Chief Executive at Blueheath - the internet-enabled stockless wholesaler he founded in 2001. He was a partner at McKinsey and Company from 1995 to 2001, and head of the UK retail practice. He read Mathematics at the University of Cambridge and has a PhD in Theoretical Computer Science from the University of Edinburgh.

The British Heart Foundation
Coronary heart disease is the UK’s single biggest killer. For over 50 years we’ve pioneered research that’s transformed the lives of people living with heart and circulatory conditions. Our work has been central to the discoveries of vital treatments that are changing the fight against heart disease. But so many people still need our help. From babies born with life-threatening heart problems to the many Mums, Dads and Grandparents who survive a heart attack and endure the daily battles of heart failure. Join our fight for every heartbeat in the UK. Every pound raised, minute of your time and donation to our shops will help make a difference to people’s lives. For more information visit bhf.org.uk.

Share this page: